Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
MANH
NVO
Add up to 3 more stocks
MANH
Manhattan Associates, Inc.
-1.56%
$201.82-3.20Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$11.77B
52W Range
$119.06 - $227.03
NVO
Novo Nordisk A/S
-2.14%
$43.07-0.94Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$191.26B
52W Range
$35.12 - $64.16
Different business models: this comparison spans Technology, Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 57.83 | 10.61 |
| Forward P/E | 36.71 | N/A |
| P/B Ratio | 74.71 | 5.67 |
| P/S Ratio | 10.45 | 3.75 |
| P/FCF Ratio | 29.48 | 25.68 |
| EV/EBITDA | 41.45 | 7.85 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 54.6% | 80.6% |
| Operating Margin | 24.3% | 43.1% |
| Net Margin | 18.7% | 35.3% |
| ROE | 133.5% | 53.5% |
| ROA | 30.1% | 19.9% |
| ROIC | 90.9% | 30.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.98 | 0.87 |
| Quick Ratio | 0.98 | 0.66 |
| Debt/Equity | 0.34 | 0.63 |
| Interest Coverage | N/A | 30.34 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 4.1% |
| Payout Ratio | N/A | 44.3% |
| Yrs of Dividend Growth | 0 | 6 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.